Health Insurance (General Medical Services Table) Amendment (Various Measures) Regulation 2014
 
Select Legislative Instrument No. 10, 2014
I, Quentin Bryce AC CVO, Governor‑General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following regulation under the Health Insurance Act 1973.
Dated 26 February 2014
Quentin Bryce
Governor‑General
By Her Excellency’s Command
Peter Dutton
Minister for Health
 
 
  
  
Contents
1............ Name of regulation.............................................................................. 1
2............ Commencement................................................................................... 1
3............ Authority............................................................................................. 1
4............ Schedule(s)......................................................................................... 1
Schedule 1—Amendments                                                                                                2
Health Insurance (General Medical Services Table) Regulation 2013            2
 
1  Name of regulation
                   This regulation is the Health Insurance (General Medical Services Table) Amendment (Various Measures) Regulation 2014.
2  Commencement
                   This regulation commences on 1 March 2014.
3  Authority
                   This regulation is made under the Health Insurance Act 1973.
4  Schedule(s)
                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1—Amendments
  
Health Insurance (General Medical Services Table) Regulation 2013
1  Subclause 1.1.3(2) of Schedule 1 (paragraph (a) of the example)
Omit “health workers”, substitute “and Torres Strait Islander health practitioners”.
2  At the end of clause 2.5A.2 of Schedule 1
Add:
                   ; (p)  Rett’s disorder.
3  Subclause 2.16.4(3) of Schedule 1
Omit “health worker”, substitute “and Torres Strait Islander health practitioner”.
4  Schedule 1 (item 11820)
Repeal the item, substitute:
 
11820
Capsule endoscopy to investigate an episode of obscure gastrointestinal bleeding, using a capsule endoscopy device (including administration of the capsule, associated endoscopy procedure if required for placement, imaging, image reading and interpretation, and all attendances for providing the service on the day the capsule is administered) if:
(a) the patient to whom the service is provided:
(i) has recurrent or persistent bleeding; and
(ii) is anaemic or has active bleeding; and
(b) an upper gastrointestinal endoscopy and a colonoscopy have been performed on the patient and have not identified the cause of the bleeding; and
(c) the service has not been provided to the same patient on more than 2 occasions in the preceding 12 months; and
(d) the service is performed by a specialist or consultant physician with endoscopic training that is recognised by The Conjoint Committee for Recognition of Training in Gastrointestinal Endoscopy; and
(e) the service is not associated with balloon enteroscopy
2 039.20
5  Schedule 1 (item 11823, column headed “Description”, paragraph (c))
Omit “double”.
6  Subclauses 2.42A.1(1) and (2) of Schedule 1
Omit “18375”, substitute “18377”.
7  Schedule 1 (after item 18375)
Insert:
 
18377
Botulinum toxin type A (Botox), injection of, for the treatment of chronic migraine, including all injections in 1 day, if:
(a) the patient is at least 18 years of age; and
(b) the patient has experienced an inadequate response, intolerance or contraindication to at least 3 prophylactic migraine medications before commencement of treatment with botulinum toxin, as manifested by an average of 15 or more headache days per month, with at least 8 days of migraine, over a period of at least 6 months, before commencement of treatment with botulinum toxin; and
(c) the requirements relating to botulinum toxin type A under the Pharmaceutical Benefits Scheme are complied with
For each patient—applicable not more than twice except if the patient achieves and maintains at least a 50% reduction in the number of headache days per month from baseline after 2 treatment cycles (each of 12 weeks duration)
124.85
8  Schedule 1 (items 30680, 30682 and 30684)
Omit “Double balloon”, substitute “Balloon”.
9  Schedule 1 (item 30684)
Omit “or laser”, substitute “, laser coagulation or argon plasma”.
10  Schedule 1 (item 30686)
Omit “Double balloon”, substitute “Balloon”.
11  Schedule 1 (item 30686)
Omit “or laser”, substitute “, laser coagulation or argon plasma”.